皇冠篮球比分网

  Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory
 
logn  
  home
 
  Products Center
  API
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Cabazitaxel
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
7-Troc-Paclitaxel
7,10-di-Troc-Docetaxel
more...
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
more...
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
Ethyl (2R,3S)-3-Phenylisoserine Ester
more...
 
Your location:Home>>R & D>>Technology Strength
 
 



Our R&D center is located in Central Shanghai, currently equipped with 18 R&D professionals and a full set of experimental equipments.

In the high-tech industry, technology innovation is the primary driven force and source strength for the company's continuous development. The company centers on innovation, aims at the internationally advanced, domestical blank and continuable projects, deeply committed in research and development. By taking in full consideration of reasonable arrangement for short term and long term projects, it is able to complement the basic research and the applicable development, maintain its leading position in the R&D of Anti-cancer APIs and its relevant products.



 
 
CopyRight(C)2006, All Rights Reserved. Supported by    Copyright Notice
HOME About us Products R & D Production and QA Contact us CHINESE